Processa Pharmaceuticals, Inc. Quarterly Entity Common Stock, Shares Outstanding from Q2 2013 to Q2 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Processa Pharmaceuticals, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q2 2013 to Q2 2024.
  • Processa Pharmaceuticals, Inc. Entity Common Stock, Shares Outstanding for the quarter ending August 1, 2024 was 3.26M shares, a 86.7% decline year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 3.26M -21.3M -86.7% Aug 1, 2024 10-Q 2024-08-13
Q1 2024 2.86M -21.7M -88.4% Mar 21, 2024 10-K 2024-03-29
Q3 2023 24.6M +8.64M +54% Nov 1, 2023 10-Q 2023-11-13
Q2 2023 24.5M +8.68M +54.7% Aug 4, 2023 10-Q 2023-08-10
Q1 2023 24.6M +8.71M +55% Mar 27, 2023 10-K 2023-03-30
Q3 2022 16M +275K +1.75% Nov 1, 2022 10-Q 2022-11-08
Q2 2022 15.9M +252K +1.61% Aug 4, 2022 10-Q 2022-08-11
Q1 2022 15.8M +322K +2.08% Mar 31, 2022 10-K/A 2022-05-02
Q3 2021 15.7M +5.15M +48.7% Nov 2, 2021 10-Q 2021-11-12
Q2 2021 15.6M +10.1M +183% Aug 2, 2021 10-Q 2021-08-12
Q1 2021 15.5M +10M +183% Mar 19, 2021 10-K 2021-03-25
Q3 2020 10.6M -27.8M -72.5% Oct 31, 2020 10-Q 2020-11-12
Q2 2020 5.52M -33.3M -85.8% Jul 31, 2020 10-Q 2020-08-05
Q1 2020 5.49M -33.2M -85.8% Apr 30, 2020 10-Q 2020-05-15
Q3 2019 38.4M -270K -0.7% Nov 5, 2019 10-Q 2019-11-14
Q2 2019 38.8M +127K +0.33% Jul 31, 2019 10-Q 2019-08-14
Q1 2019 38.7M +3.4M +9.64% Mar 15, 2019 10-K/A 2019-04-08
Q3 2018 38.7M +14M +56.6% Nov 13, 2018 10-Q 2018-11-14
Q2 2018 38.7M +27.7M +251% Aug 2, 2018 10-Q 2018-08-14
Q1 2018 35.3M +24.3M +220% Apr 13, 2018 10-K 2018-04-16
Q3 2017 24.7M +13.7M +124% Sep 30, 2017 10-Q 2017-11-20
Q2 2017 11M 0 0% Jun 30, 2017 10-Q 2017-10-04
Q1 2017 11M 0 0% Mar 31, 2017 10-Q 2017-10-04
Q4 2016 11M 0 0% Dec 31, 2016 10-K 2017-09-25
Q3 2016 11M 0 0% Sep 30, 2016 10-Q 2017-09-08
Q2 2016 11M 0 0% Jun 30, 2016 10-Q 2017-08-30
Q1 2016 11M -43.7K -0.4% Mar 31, 2016 10-Q 2017-08-07
Q4 2015 11M +1.52M +16% Dec 31, 2015 10-K 2017-06-19
Q3 2015 11M +2.58M +30.6% Sep 30, 2015 10-Q 2015-12-01
Q2 2015 11M +2.59M +30.7% Jun 30, 2015 10-Q 2015-08-19
Q1 2015 11.1M +2.79M +33.7% Mar 31, 2015 10-Q 2015-05-15
Q4 2014 9.5M +1.41M +17.5% Dec 31, 2014 10-K 2015-04-14
Q3 2014 8.43M +388K +4.82% Sep 30, 2014 10-Q 2014-11-13
Q2 2014 8.43M +1.4M +19.9% Jun 30, 2014 10-Q 2014-08-19
Q1 2014 8.27M Mar 31, 2014 10-Q 2014-05-14
Q4 2013 8.08M Dec 31, 2013 10-K 2014-03-27
Q3 2013 8.05M Sep 30, 2013 10-Q 2013-11-08
Q2 2013 7.03M Jun 30, 2013 10-Q/A 2013-09-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.